Modeling Cardiovascular Protection With SGLT Inhibition in Type 1 Diabetes: A Risk-Based Approach to Guide Therapy?

Scritto il 18/03/2025
da Luxcia Kugathasan

No abstract

Diabetes Care. 2025 Mar 18:dc242840. doi: 10.2337/dc24-2840. Online ahead of print.

NO ABSTRACT

PMID:40100966 | DOI:10.2337/dc24-2840